Connecticut

GranuFlo news Updates, Dialysis Medication Lawsuits Consolidation

Written by

GranuFlo and Naturalyte heart attack form dialysis medication lawyers are filing lawsuits for cardiac injury and death from GranuFlo and Naturalyte.

There was a class 1 recall of GranuFlo last year due to cardiac injury during or just after dialysis treatment. NaturaLyte is a liquid acid concentrate and GranuFlo is a dry acid concentrate. Both products contain sodium acetate that converts to bicarbonate at higher then expected rates leading to immediate cardiac arrest in many dialysis patients and cardiac injury bin others.
At year s end in 2012,a Motion to Consolidate the cases into multidistrict litigation (MDL) for all federal lawsuit was filed. A request has been filed with the U.S. Judicial Panel on Multidistrict Litigation asking that all Naturalyte and GranuFlo lawsuits filed in U.S. District Courts throughout the country be consolidated for pretrial proceedings in the District of Massachusetts.
Early in 2013, Fresenius said in court papers that it agreed that consolidation of the NaturaLyte and Granuflo litigation was appropriate and supported the transfer of the cases to the District of Massachusetts
On January 3, several Plaintiffs with pending lawsuits have objected to centralizing the cases in Massachusetts, indicating that the litigation should be consolidated in the southeast, because of the number of cases filed in that region. Their choices are the Southern District of Mississippi and the Northern District of Alabama have been requested. Many Florida retired seniors are dialysis patents and have been injured or killed sue to a cardiac episode from GranuFlo or Naturalyte.

Dialysis Injury Help Center, GranuFlo Naturalyte Helpline

Written by

Lawyers for GranuFlo and Naturalyte are filing lawsuits for dialysis injury from Granuflo and Naturalyte. Fresenius Medical Care’s dialysis product GranuFlo is a medication that dialysis centers use to treat acute and chronic kidney failure.

Your kidneys clean the blood of waste products and help maintain the body’s pH level. When they fail, the body’s pH level become more acidic than is should be. Kidney failure is treated with chemicals that help the body convert ph level. These substances convert into the alkaline substance bicarbonate, which neutralizes some of the acid buildup in the blood stream.
GranuFlo and Naturalyte have had issues with this conversion and have shown instances of immediate heart attacks as a side effect. GranuFlo contains more bicarbonate than other dialysates.

The June 2012 New York Times article describes Fresenius’s knowledge of these risks of granuFlo and Naturalyte and the product’s high bicarbonate level. According to the article, Fresenius sent a memo to its clinics warning that the higher bicarbonate levels in GranuFlo had caused 941 heart attacks in the company’s own clinics in 2010, leading the company’s researchers to estimate that GranuFlo increases a patient’s risk of heart attack by six times. Fresenius did not send the memo to GranuFlo-using clinics that the company didn’t own, however, until March 29, 2012, when the FDA consequently began investigating Fresenius for possible violations of federal regulations, the Times reports.

Currently GranuFlo and Naturalyte lawyers are accepting claims against Fresenius for immediate hear attack form their GranuFlo and Naturalyte products. A number of dialysis patients may have already been injured by GranuFlo. If GranuFlo diaysis medication caused a sudden heart attack or cardiac arrest, hemodialysis cardiac arrest or cardiopulmonary arrest, stroke, or arrhythmia speak to a GranuFlo lawyer now by calling the GranuFlo legal team of free legal Shield. We seek justice for seniors.

Mesothelioma Lawsuits, Mesothelioma Lawyers, Asbestos, Lung Cancer

Written by

Mesothelioma is a fatal lung cancer caused by exposure to asbestos. Certain work environments are more prone to causing mesothelioma.

  • Shipyard Workers
  • Construction Workers
  • Power Plant Workers
  • Chemical Plant Workers
  • Industrial Workers
  • Insulators
  • Boiler Workers
  • Auto Mechanics

Types of mesothelioma

  • Pleural mesotheliomas start in the chest.
  • Peritoneal mesotheliomas begin in the abdomen.

Symptoms of Mesothelioma

  • Shortness of breath and
  • A heavy feeling in the chest area.
  • Pain under the rib cage.
  • Pain or swelling in the abdomen.
  • Lumps in the abdomen.
  • Weight loss for no known reason.

Mesothelioma Comes from Inhaling Asbestos For Long Periods Of Time

When a person breathes in the small asbestos fibers, they remain in the lungs and cause scar tissue to form on the the tiny air sacs where oxygen and carbon dioxide are exchanged. The amount of oxygen that is available to the body is reduced through asbestos exposure and worsened through repeated inhalations for long periods of time.

Notable asbestos verdicts in the United States include:
Mississippi

In May 2011, the current largest plaintiff s asbestos verdict was awarded to a former oil refinery worker. Union Carbine and Chevron Phillips Chemical were instructed to pay the man $322 million.
San Francisco, California

Alfred Todak, a former Navy electrician, was awarded $22.7 million, and his was wife was awarded $11 for loss of consortium.
Madison County, Illinois

Madison County s asbestos verdicts have typically favored the plaintiff, including the 2000 Hutchinson v. Shell Oil Company case in which a man was awarded a total of $34.1 million.

Incidence of Mesothelioma

State/Region Incidence per 100,000
New Jersey 1.52
Seattle-Puget Sound 1.44
Louisiana 1.37
Connecticut 1.08
Greater California 1.06
Utah 1.02
New Mexico 0.99
Detroit 0.89
Kentucky 0.85
Iowa 0.80
Georgia 0.70

The six states with the highest mesothelioma death rates include: Maine, Wyoming, West Virginia, Pennsylvania, New Jersey and Washington

Mesothelioma Lawyers

If you or a loved one has been diagnosed with mesothelioma or asbestos related cancer call our mesothelioma helpline today. We will connect you with an experienced mesothelioma, mass tort lawyer. Mesothelioma lawsuits are mass torts and must be handled by an experienced mass tort lawyer.

Meningitus Outbreak Due To Steroid Medication, Meningitus Lawyers Ready as 26 States Effected

Written by

A menigitus outbreak is now expanding to 26 states. The outbreak is linked to a contaminated shipment of steroid medication from a Massachusetts compounding pharmacy. Product liability lawyers are looking at injuries and potential deaths increasing. According to the product liabilities lawyers of Free Legal Shield there may be a huge number of pharmaceutical liability lawsuits filed against the manufacturer of thi s product. A manufacturer can be held liable for injury and death due to contamination of it s products. The hardest hit has been a clinic in Nashville Tennessee.


By

Michelle Castillo /
CBS News/ October 4, 2012, 3:22 PM
Meningitis outbreak may affect more than 23 states

The Centers for Disease and Control and Prevention (CDC) and Food and Drug Administration (FDA) announced today they are advising medical professionals not to use any products manufactured by the New England Compounding Center in Framingham, Mass., due to an outbreak of fungal meningitis tied to some medications made by the company.

Three lots of the company s preservative-free methylprednisolone acetate that go back to July 2012 have been recalled and are believed to be the cause of the recent outbreak. Thirty-five cases of fungal meningtitis in six states have been identified, with five deaths. The majority of the cases, 25 in total, have been discovered in Tennessee.

"Given the severity of illness, we believe these precautionary measures are warranted to protect public health," Ilisa Bernstein, director of the FDA office of compliance, said to reporters during a conference call today.

Meningitis outbreak sickens 35 in 6 states, kills 5
Tenn. meningitis outbreak tied to steroid shots

Dr. Benjamin Park, medical epidemiologist with the Centers for Disease Control and Prevention, told reporters that 23 states may have received shipments of the tainted product. These states include: California, Connecticut, Florida, Georgia, Idaho, Illinois, Indiana, Maryland, Michigan, Minnesota, North Carolina, New Hampshire, New Jersey, Nevada, New York, Ohio, Pennsylvania, Rhode Island, South Carolina, Tennessee, Virginia, Texas and West Virginia. A total of 75 facilities may have received product from one of these three recalled lots.


Deadly meningitis outbreak in U.S.

However, because the New England Compounding Center is licensed in all 50 states, there is a possibility contaminated products may be in other areas, Bernstein said.

"We don t know the scope of this," she admitted.

The initial three-lot recall by the New England Compounding Center involved 17,676 vials, the CBS News Investigative Team reported. There were two complaints filed against the company one in 2002, one in 2003 that were investigated and as a result the company entered into an agreement in 2006 with the Massachusetts Department of Health to correct any deficiencies. That same year, the FDA warned the company against compounding topical anesthetic creams for general distribution.

In March 2012, a complaint unrelated to the meningitis case was filed against the company regarding the potency of its eye medication. That complaint is still open and pending, according to the investigative team.

Play Video
Meningitis outbreak linked to Mass. pharmacy

Fungal meningitis is a non-contagious form of the disease. It is often caused by fungus normally found in leaf mold. Authorities said some people were experiencing mild stroke-like symptoms, including slurred speech, and difficulty walking and urinating. Other fungal meningitis symptoms include worsening and severe headache, nausea, dizziness and fever.

It can be treated with high-dose antifungal medications, usually given intravenously in a hospital. The earlier the disease is diagnosed and treated, the better the chances of survival are.

"We think that early antifungal treatment can improve the outcome of these patients," Park said.

Park said that the CDC was notified of a patient with an onset of meningitis 19 days after receiving an epidural steroid injection on Sept. 21 in Tennessee. Although all initial cultures were negative, fungus was isolated from the patient s cerebral spinal fluid. On Sep. 28, the CDC was notified of cases outside of Tennessee.

In total, one case in North Carolina, two cases in Florida, four cases in Virginia, two cases in Maryland and one case in Indiana have been discovered in addition to the 25 cases in Tennessee. Three people have died in Tennessee, as well as one person from Virginia and one person from Maryland.

The victims tend to be elderly because of the nature of patients who receive spinal epidural injections because of lower back pain. Overall, many of the patients were somewhat healthy until infection.

Play Video
Woman may have been exposed to meningitis

On Oct. 1, the New England Compounding Center voluntarily shut down their manufacturing center. During a FDA investigation of the plant, the investigators discovered contaminants in an unopened vial.

"Materials from an unopened vials was looked at under the microscope at an FDA lab and what was looked at under the microscope looked like a fungal matter," an FDA spokesperson confirmed.

The FDA added that they are working with the firm to get more information about their products. The

GranuFlo Lawyers, NaturaLyte Lawsuits

Written by

Fresenius Medical is the manufacturer of GranuFlo and NaturaLyte acid concentrate. These are drugs used in dialysis treatment. There has been a recall of these dialysis drugs and lawsuits are being filed.

Injury and death has resulted from these drugs:

  • GranuFlo cardiovascular death,
  • GranuFlo sudden cardiac death,
  • GranuFlo cardiopulmonary arrest,
  • GranuFlo heart attack,
  • GranuFlo catastrophic cardiovascular injuries

Fresenius manufactures GranuFlo and NaturaLyte used in dialysis. These drugs cause alkalosis, a condition associated with an increase in cardiovascular fatalities.

The FDA received complaints describing alkali dosing errors that occurred during hemodialysis using dialysate concentrates containing acetic acid and acetate. When metabolized, these potential sources of alkali can contribute to elevated bicarbonate levels in patients undergoing hemodialysis.

This can contribute to metabolic alkalosis, which is a significant risk factor associated with :

Low blood pressure

Cardiopulmonary arrest

Cardiac arrhythmia

Sudden heart attack

Stroke

Hemodialysis cardiopulmonary arrest

A study which was conducted between January and December of 2010 found that patients with pre-dialysis bicarbonate levels greater than 28mEq/L were 4.7 times more likely to suffer a cardiac arrest. The study also discovered that patients with pre-dialysis potassium lower than 4 mEq/L had a 6.3 times higher risk of cardiac arrest.

In May 2012 the FDA notified health care providers to consider the presence and quantity of acetate, citrate, and/or acetic acid in dialysate concentrates when determining the patients’ dialysate prescription.

There is a GranuFlo and NaturaLyte Class 1 Recall

Serial numbers for recalled Naturalyte Liquid Acid Concentrate range from:

08-0231-4, 08-1001-0, 08-1201-8, 08-1231-3, 08-1251-1, 08-1301-4, 08-2201-5, 08-2231-2, 08-2251-0, 08-2301-3,08-2351-8, 08-3201-4, 08-3231-1, 08-3251-9, 08-3301-2, 08-4123-1, 08-4223-7, 08-4225-1, 08-4230- 2, 08-4231-0, 08-4323-5, 08-4325-1, 13-1251-1, 13-2201-5, 13-2231-2, 13-2251-0, 13-3231-1, 13-3251-9, 13-4123-1, 13-4220-1, 13-4225-1, 13-4325-

Serial numbers for recalled Naturalyte GranuFlo (powder) Acid Concentrate range from:

OFD1201-3B, OFD1251-3B, OFD2123-3B, OFD2201-38, OFD2220-3B, OFD2223-3B, OFD2225-3B, OFD2231-3 B, OFD2251-3B, OFD2301-3B, OFD2323-3 B, OFD2325-3B, OFD3201-3B, OFD3231-3B, OFD3251-3B, OFD3301-3B

GranuFlo & NaturaLyte is one of the most widely prescribed dry acid products used for dialysis at Fresenius clinics, as well as other hemodialysis centers that purchase their dialysis supplies from Fresenius. It is estimated that 125,000 patients in non-Fresenius clinics are treated with GranuFlo.

Dilaysis Patient Alert

If you, a loved one or someone you care for has been injured by these products contact us for a GranuFlo and NaturaLyte lawsuit.

Bladder Sling Lawyers, Vaginal Mesh Lawsuits

Written by

The bladder mesh is a vaginal mesh product primarily used for urinary incontinence. This mesh sling has caused severe complications and bladder mesh lawyers are filing lawsuits. Many women with a bladder mesh do not realize they are eligible to file a vaginal mesh lawsuit.

What is a Bladder Sling?

Urethral sling or bladder sling is used to treat urinary incontinence by placing a sling around the urethra to lift it back into a normal position and to exert pressure on the urethra to aid urine retention. The sling is attached to the abdominal wall. A bladder sling is a mesh device and is part of the vaginal mesh litigation. The complications of a failed bladder sling is increased incontinence or trouble voiding. Many women have needed to self catherize.

Bladder Sling Complications?

According to the July 2011 FDA news release, the most common complications associated with surgical mesh bladder slings is erosion thru the vaginal wall or into the bladder, pain during sexual intercourse, bleeding, infection, perforation of various pelvic organs (bladder, colon, vaginal walls), and urinary incontinence or problems voiding as well as; neuromuscular problems, emotional problems, mesh contraction/shrinkage, and even a reoccurrence of POP and/or SUI.

Bladder sling lawsuits are being filed on a contingency fee basis against the mnaufacturers of the bladder sling:

Bard Avaulta Support System
AMS Elevate Prolapse Repair System
AMS Apogee Vault Suspension System
AMS Perigee System
AMS Monarc Sling System
AMS Sparc Sling System
Ethicon Gynecare Gynemesh
Ethicon Gynecare Prolene Soft Mesh
Ethicon Gynecare Prolift Pelvic Floor Repair System
Ethicon Gynecare TVT Transvaginal Sling
Boston Scientific Pinnacle Pelvic Floor Repair Kit
Boston Scientific Uphold Vaginal Support System
UGYTEX Dual Knit Mesh
Coviden IVS Tunneler Sling

Contact us today.

Stryker Hip Replacement Lawyers, Stryker Hip Replacement Helpline

Written by

Adding to the Zimmer and DePuy metal on metal hip replacement Stryker has recalled it s latest metal component hip replacement implant. Stryker has voluntarily recalled the Rejuvenate metal component hip replacement implant and ABG II modular- neck stems
Stryker has voluntarily stopped market distribution of these hip replacements due to increased risk of injury. The hip replacement implants have been shown to fret or corrode, harming body tissue and causing pain and swelling. Other injuries include:

  • Severe inflammatory reactions
  • Pain in the groin
  • metal toxicity ort poisoning
  • high metal levels in the blood
  • need for additional surgery
  • Breakdown of muscles, tendons and other soft tissues in and around the hip joint
  • Loss of surrounding bone
  • Loss of mobility

While other types of hip implants such as those made by Johnson & Johnson and DePuy Orthopaedics Inc. involve a metal ball rubbing against a metal socket, the Stryker Rejuvenate products involve a metal neck inside a metal stem. The Stryker Hip replacement Helpline and hip replacement lawyers are reaching out to all victims of the failed device for a potential multi district litigation.

The products have metal components and although they are not metal on metal run the same risks of chromium and cobalt toxicity poisoning. If you have been injured you are advised to contact your doctor immediately and contact the Stryker Hip Replacement Helpline for a Stryker lawyer

NuvaRing Potential for Blood Clots and Pulmonary Embolism

Written by

NuvaRing lawyers are Reviewing cases for Blood Clots From the NuvaRing Birth Control Device.

Yaz and Yasmin have similiar lawsuits pending.

The NuvaRing birth control device was first approved by the FDA in 2001. In October 2011, the FDA released a drug safety study report indicating the NuvaRing was associated with a significantly higher risk of developing deep vein thrombosis and pulmonary embolisms than standard low-dose estrogen birth control pills. Now, according to new results published this month in the British Medical Journal, women using the vaginal ring are at a significantly higher risk for venous thrombosis compared to those taking earlier generation oral contraceptive birth control.

All hormonal contraceptions come with some risk of blood clots, which can lead to other complications like deep vein thrombosis and even life-threatening pulmonary embolism and stroke. Danish researchers, however, studied pregnant women ages 15-49 who were free of any prior thrombotic disease, between 2001 and 2010, and discovered that women who use vaginal rings like the NuvaRing for contraception have a 6.5 times increased risk of confirmed venous thrombosis compared with non-users of hormonal contraception.

The researchers further noted that “the vaginal ring conferred a 90% higher risk of venous thrombosis than did combined oral contraceptives containing levonorgestrel, bringing the risk to the same level as that of combined oral contraceptives with third and fourth generation progestogens”—such as Yaz and Yasmin. The researchers concluded that, "women are generally advised to use combined oral contraceptives with levonorgestrel or norgestimate, rather than to use transdermal patches or vaginal rings."

NuvaRing Lawyers blodd clot lawsuits for NuvaRing.

NuvaRing lawsuits were consolidated on August 22, 2008 in the NuvaRing MDL in the U.S. District Court for the Eastern District of Missouri under Judge Rodney Sippel, and in the Bergen County Superior Court of New Jersey before Judge Brian R. Martinotti. The first NuvaRing MDL trial is expected to take place in January 2014.

If you or a loved one has had a blood clot related medical condition from Nuvaring contact us immediately to discuss the Nuvaring consolidated lawsuits.

Attention DePuy Hip Replacement Lawsuit Filing Ending August 2012

Written by

Breaking news; If you were injured by the DePuy hip Recall You must file your lawsuit now. Filing deadline August 2012

Most DePuy ASR Lawsuits Must Be Filed Before August 2012

Posted May 18, 2012 4:57 PM

DePuy ASR hip implant patients in most states who do not file lawsuits before August 23, 2012 may lose their rights to compensation or to file a lawsuit. Every state has a law called the statute of limitations that sets a limited time period in which a lawsuit for compensation can be filed. If a person with a legal claim or legal case fails to have a lawsuit filed on their behalf within this time period their claim can be forever barred. In summary, people who do not assert their rights in court within a limited time lose those rights and can never thereafter bring that claim.
Why is the Statute of Limitations for Most ASR Hip Implant Patients This August?
Every state has its own time limit for filing lawsuits called the Statute of Limitations. DePuy and Johnson and Johnson, the manufacturers of the ASR Hip Implant, have a right to have lawsuits dismissed or decided in their favor regardless of the injuries if the lawsuit is not filed in time to comply with the statute of limitations.
Most states in the United States use a two year time period for the statute of limitations. Other states may have a 1 year up to a six year time period for the statute of limitations. Different states use different rules to calculate when these time periods start running and when it is too late to bring a lawsuit. These calculations can be difficult to make and there have been many lawsuits over the running of the statutes of limitations in different types of cases. Each person’s case should be carefully evaluated individually by an experienced lawyer because individual circumstances can affect calculating this time period. This blog is for general information and awareness and you should not use this information to make your own calculation to rely on for your case for the statutes of limitations.
This two year statute of limitations will run for many DePuy ASR hip implant cases because the official DePuy Recall Notice that received widespread publicity was issued on August 24, 2010. The two year period from that Recall Notice will expire on August 23, 2012. Thus, lawsuits for injured ASR patients must be filed in those states with a two year statute of limitations or it may be too late for those patients to make a claim.
Which States Have a Two Year Statute of Limitations
Arizona, Alabama, Alaska, California, Colorado, Connecticut, Delaware, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, North Dakota, New Jersey, Ohio, Oklahoma, Oregon, Pennsylvania, Texas, Utah, Virginia, and West Virginia are the states with a two year statute of limitations for injury cases.
However, the calculations used to measure the two year time periods are different in different states and it is important to have each case calculated by an experience attorney to be sure that the time period does not run out before the lawsuit is filed.
For example, the two year statute of limitations in Virginia is unusual in that the two year time period in that state runs from when the person first has pain or is aware of an injury even if that was before the recall of before they had any idea that DePuy might be responsible. So in Virginia it is likely that the statute of limitations may have already run on some cases where the person had pain from their hip implant before the recall date. It is possible that someone reading this blog could have a statute of limitations that will run tomorrow or next week!
Immediate individual legal advice is critical to making sure that the Statute of Limitation is not missed.
There are many states other than those listed above that have a statute of limitations of two years from the date of death if the implant caused a death. Some states have longer statutes of limitations for injury cases than for death cases.
Are There Exceptions to the Statute of Limitations?
There are few exceptions to the Statute of Limitations. One of the clearest is the Sailors and Soldiers Relief Act which can toll the statute of limitations for some active members of the military while they are in the service of our country. Tolling of the Statute of Limitations means that the time period is stopped from running. That means that some active military people could wait many years before having to file their cases. Our firm has had other types of cases where the statute of limitations has been tolled for decades while a military person is in active service.
Many states have what is called a “Discovery Rule” which means that the Statute of Limitations does not start until a person would reasonably know that they might have a liability claim. I believe many judges would rule that the widespread public dissemination of the DePuy Recall Notice of August 24, 2010 would start the clock running on the statute of limitations even if an individual person did not hear about it or know about it because the test is usually an objective test about what a reasonably informed person would know.
There is another highly complex legal rule called the “American Pipe Rule” that may be applied in some states if a class action is pending to toll the time period for an individual lawsuit for a person who would be a member of that class action. This theory should not be relied on for DePuy ASR cases because there is no viable class action that I know of. The ASR cases are coordinated for pretrial purposes in a federal multidistrict proceeding called an MDL but this is not a class action and will not toll or stop the statute of limitations from running in an individual case unless an individual case is filed for that person.
Mental incompetence can be an exception in some states that could extend the statute of limitations. For example, someone with severe Alzheimers disease might qualify in some states for an extension to the statute of limitations.
Final Advice on the Statute of Limitations for ASR Lawsuits
Every person with a DePuy ASR Hip Implant should have a detailed review of the statute of limitations done by an attorney experienced in medical product liability cases. This review should be done immediately because once the statute of limitations has run there is no way to reopen or restart it. Once the statute of limitations has run it is too late to ever bring a lawsuit for harms and injuries from the defective ASR metal on metal hip implants.

Pradaxa Breaking News, Pradaxa lawyers, Pradaxa Lawsuits, Pradaxa Bleeding

Written by

Pradaxa has warnings for excessive bleeding. Pradaxa Helpline is concerned about Pradaxa and the elderly

The Pradaxa Helpline Has Pradaxa Lawyers to Help You

LONDON | Fri May 25, 2012 6:07am EDT

(Reuters) Doctors and patients should be given clearer guidance on how to avoid bleeding risks when using Boehringer Ingelheim s new stroke prevention pill Pradaxa, European regulators said on Friday.

The European Medicines Agency said data continued to confirm the positive benefit-risk balance of the anticoagulant medicine, despite cases of fatal bleeding, but advice on the risks should be strengthened.

Pradaxa is the first in a new class of medicines aimed at replacing the old and problematic drug warfarin. It is designed for use after hip and knee surgery and to prevent strokes in patients with atrial fibrillation, a form of irregular heartbeat common among the elderly.

Rival drugs include Xarelto, from Bayer and Johnson & Johnson, and Eliquis, from Bristol-Myers Squibb and Pfizer.

Pradaxa is an anticoagulant. Anticoagulants effect the clotting time of the blood. Pradaxa is described as a prescription blood-thinning medicine used to reduce the risk of stroke and blood clots in people with atrial fibrillation not caused by a heart valve problem. With atrial fibrillation, part of the heart does not beat the way it should. This can cause blood clots to form, increasing your risk of a stroke. Pradaxa lowers the chance of blood clots forming in your body. There is a chnce of excessive bleeding on Pradaxa that can be fatal.

We can locate a Pradaxa lawyer to help you: